Page last updated: 2024-10-23

azathioprine and Hyperoxaluria, Primary

azathioprine has been researched along with Hyperoxaluria, Primary in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Hyperoxaluria, Primary: A genetic disorder characterized by excretion of large amounts of OXALATES in urine; NEPHROLITHIASIS; NEPHROCALCINOSIS; early onset of RENAL FAILURE; and often a generalized deposit of CALCIUM OXALATE. There are subtypes classified by the enzyme defects in glyoxylate metabolism.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casale, AJ1
Leichter, HE1
Sheth, KJ1
Segura, AD1
Lawson, RK1

Other Studies

1 other study available for azathioprine and Hyperoxaluria, Primary

ArticleYear
Renal transplantation in a child with primary oxalosis.
    Child nephrology and urology, 1990, Volume: 10, Issue:2

    Topics: Azathioprine; Child, Preschool; Graft Rejection; Humans; Hyperoxaluria, Primary; Kidney Transplantat

1990